NOV 11·Zacks CommentaryMed
UG Q3 Profit Falls Y/Y on Weak Cosmetics Sales, Stock Declines 10%
United-Guardian's Q3 earnings fall y/y on weak cosmetic sales, pressuring margins and sending UG shares down even as pharma and medical lines grow.
StockConsumer Defensive · Household & Personal Products
$UG
UNITED GUARDIAN INC
Price · $UGvia TradingView
AI sentiment · 7d0 articles
No enriched coverage for $UG in the last 7 days.
Insider · 30dFeed →
No SEC Form 4 filings for $UG in the last 30 days.
Top stories · $UGMore →
SEP 9·Zacks Commentary
FONAR's Stock Advances 5% in Three Months: Key Trends Ahead
FONR leverages hybrid MRI tech and a strong balance sheet to navigate industry headwinds, though rising costs and regulatory risks tied to claim collections remain key challenges.
AUG 14·Zacks Commentary
UG Q2 Earnings Fall Y/Y on Weak Cosmetic Sales, Pharma Gains
United-Guardian's Q2 earnings fall on weak cosmetic sales, partly offset by gains in pharmaceuticals and medical lubricants, with recovery hopes ahead.